Alpha Lipoic Acid Supplement Ireland: Evidence Guide 2026

Alpha lipoic acid (ALA) is one of the most researched antioxidant compounds in nutritional science — with a particularly strong evidence base in peripheral neuropathy. This guide covers what the evidence actually shows, what it does not, and what to look for in an Irish supplement.

Alpha lipoic acid (ALA, lipoic acid) definition: Alpha lipoic acid is a naturally occurring organosulfur compound produced endogenously in human mitochondria from octanoic acid, functioning as an essential cofactor in oxidative metabolism and classified as both a fat-soluble and water-soluble antioxidant found in trace quantities in organ meats, red meat, spinach, and broccoli.

What is alpha lipoic acid?

Alpha lipoic acid (ALA) — also called lipoic acid or thioctic acid — is a sulphur-containing fatty acid that plays a central role in mitochondrial energy metabolism. Every cell in the human body produces it in small amounts. Its primary biochemical job is to act as a cofactor in multi-enzyme complexes that convert glucose into usable energy (ATP) — specifically the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes.^[1]

What sets ALA apart from most other antioxidants is its dual solubility. Most antioxidants work either in fat-soluble environments (like vitamin E in cell membranes) or water-soluble environments (like vitamin C in plasma). ALA works in both — meaning it can reach and act in a wider range of cellular and tissue environments than most compounds.^[2]

ALA also has the ability to regenerate other antioxidants — including glutathione, vitamin C, and vitamin E — after they have been oxidised, which has made it a subject of significant research interest in metabolic and neurological conditions.^[3]

Alpha lipoic acid in food — natural sources

Alpha lipoic acid is found in a wide range of foods but always in small quantities. Dietary intake from normal food is estimated at approximately 1–6mg per day.^[3] The richest sources are organ meats — particularly kidney and heart — which reflects ALA's role as a mitochondrial cofactor. Tissues with high metabolic activity contain more mitochondria and therefore more ALA.

Among plant foods, spinach and broccoli are the most studied sources, with tomatoes, Brussels sprouts, and garden peas also containing detectable amounts. The key point: food sources provide nowhere near the 300–600mg doses used in clinical trials. Supplementation is used specifically when higher amounts are sought.

How alpha lipoic acid works — antioxidant mechanisms

ALA's antioxidant function operates through three interconnected pathways. First, it directly neutralises reactive oxygen species (ROS) — the unstable molecules that damage cells, proteins, and DNA when produced in excess. Second, it regenerates other depleted antioxidants — glutathione, vitamin C, and vitamin E — effectively extending their activity. Third, in its reduced form (dihydrolipoic acid, or DHLA), it is itself a potent antioxidant with direct scavenging activity.^[2]

The glutathione connection is particularly relevant. Glutathione is the body's primary intracellular antioxidant, and low glutathione levels are associated with numerous chronic disease states. ALA is proposed to increase intracellular glutathione by donating cysteine (a precursor to glutathione synthesis) and by directly reducing oxidised glutathione back to its active form. This is why ALA is often combined with N-acetyl cysteine (NAC) in research contexts — both support glutathione availability through different mechanisms.^[3]

ALA is also studied in the context of mitochondrial function and the AMPK energy-sensing pathway. In animal models and cell studies, ALA has been shown to activate AMPK — an enzyme that regulates cellular energy balance and is a target in type 2 diabetes research. Whether this translates meaningfully to humans at oral supplement doses remains an active area of research.

Neuropathy and blood sugar — what the evidence shows

Alpha lipoic acid has the most substantial human clinical trial evidence of any antioxidant supplement studied in the context of diabetic peripheral neuropathy. The evidence base spans three decades of RCTs.

The ALADIN trial (Ziegler et al., Deutsche Klinik für Diagnostik, Diabetologia, 1995, PMID 8786016) was one of the first major RCTs — using intravenous ALA at 600mg/day over 3 weeks in participants with symptomatic diabetic neuropathy. IV ALA produced significant reductions in the Neuropathy Symptom Score vs placebo. The SYDNEY 2 trial (Ziegler et al., Diabetes Care, 2006, PMID 17065669) was the pivotal oral ALA study — 181 participants, 600mg/day oral, 5 weeks. Total Symptom Score improvements were statistically significant vs placebo (p<0.001).^[4]

R-alpha lipoic acid vs alpha lipoic acid — which is better?

This is one of the most common questions about ALA supplementation. It matters because ALA exists in two mirror-image molecular forms (enantiomers): R-ALA and S-ALA. Standard synthetic ALA supplements — including Swanson's — contain a 50:50 racemic mix of both. R-ALA-only supplements also exist.

R-ALA is the form produced naturally in the human body and the form that functions as a mitochondrial cofactor. It is considered the biologically active enantiomer. S-ALA is the synthetic mirror image — not produced in the body and thought to have lower enzymatic activity. The argument for R-ALA supplements is that you get more of the active form per milligram.

The counterargument: every major human RCT showing benefit in diabetic neuropathy — including SYDNEY 2 — used standard racemic ALA (50:50 mix), not pure R-ALA. So the evidence base exists for racemic ALA, not for pure R-ALA. Additionally, R-ALA is significantly less stable than racemic ALA — it degrades more rapidly at room temperature, which affects shelf life and quality.^[3]

Alpha lipoic acid dosage, timing, and safety

The dose range used across major human trials is 300–600mg/day oral. SYDNEY 2 and several other key RCTs used 600mg/day. Some IV trials used up to 600mg/day intravenously, which has significantly higher bioavailability than oral administration. EFSA has not established a Dietary Reference Value or tolerable upper intake level for ALA as a supplement — dosing guidance is based on clinical trial data.^[4]

Timing: ALA is better absorbed on an empty stomach — food can reduce absorption by up to 50% in some studies. However, gastrointestinal side effects (nausea, stomach discomfort) are more common on an empty stomach. Taking ALA 30 minutes before a meal is a practical middle ground. Swanson's label recommends taking with food and water to minimise GI discomfort, which is the safer approach for most people.

Safety and interactions

ALA has a strong safety record at 300–600mg/day in clinical trials, including multi-year use. Key safety considerations:

Alpha lipoic acid for skin

ALA has gained attention in skincare and cosmetic applications due to its dual solubility — allowing it to penetrate both the aqueous and lipid layers of skin — and its proposed role as a topical antioxidant and photoprotective agent. ALA serums and creams have become mainstream in anti-ageing skincare ranges including The Ordinary.

The human evidence for topical or oral ALA specifically for skin improvement is modest. Preclinical studies have shown ALA can reduce UV-induced oxidative damage in skin cell models. A small human study found that topical 5% ALA cream reduced fine lines in photoaged skin, though the study was small and not replicated in large RCTs.^[3]

For oral ALA supplementation and skin benefits in healthy adults, the evidence is currently insufficient to make specific claims. Any effect would be indirect — via systemic reduction of oxidative stress, which may slow skin oxidative damage over time. This is biologically plausible but not proven in large human trials.

Alpha lipoic acid in Ireland — regulatory status and where to buy

Alpha lipoic acid is a fully legal food supplement in Ireland. It is regulated by the Food Safety Authority of Ireland (FSAI) under EU food supplement legislation (Directive 2002/46/EC as transposed into Irish law). It is not a controlled substance, does not require a prescription, and is available over the counter and online. Irish VAT of 13.5% applies to food supplement sales.^[8]

ALA may not be sold with disease treatment claims in Ireland. No EU-authorised health claim under EC Regulation 1924/2006 currently applies to alpha lipoic acid. Products marketed with claims to treat, prevent, or cure diabetic neuropathy, diabetes, or any other condition would fall under HPRA (Health Products Regulatory Authority) medicines regulation — a different regulatory framework requiring clinical authorisation that ALA supplements do not have.

Availability in Ireland has improved significantly. ALA supplements are stocked in health food stores and online. The most common doses available in Ireland are 300mg and 600mg capsules. Swanson's 600mg format is the dose used in the key SYDNEY 2 RCT.

Buying alpha lipoic acid in Ireland — comparison

Frequently asked questions — alpha lipoic acid Ireland

More evidence guides from Probiotic.ie